Severe dengue with secondary hemophagocytic lymphohistiocytosis and multiple organ dysfunction syndrome in a child
Vincent Mary1*, Vijayakumari2, Shalini3
1NICU Incharge, Kauvery Hospital, Electronic city, Bangalore
2Nurse Educator, Kauvery Hospital, Electronic city, Bangalore
3CNO, Kauvery Hospital, Electronic city, Bangalore
*Correspondence
Abstract
Background: Severe dengue is a potentially life-threatening systemic viral infection that can result in shock, severe bleeding, and organ dysfunction. Secondary hemophagocytic lymphohistiocytosis (HLH) is an uncommon but serious hyperinflammatory complication that may overlap clinically with severe dengue and contribute to prolonged fever, cytopenias, and multiorgan dysfunction.
Case presentation: A child presented with high-grade fever, a two-week history of cough and cold, generalized papular skin rashes, vomiting, reduced oral intake, and decreased urine output. Initial investigations revealed leukopenia, with a total leukocyte count of 3,490/µL, while the platelet count was initially within the normal range. A BioFire respiratory panel was positive for Influenza A. During hospitalization, the child developed progressive cytopenias, persistent fever, abdominal pain, and clinical deterioration, necessitating transfer to the Paediatric Intensive Care Unit (PICU). The PICU course was complicated by shock, severe thrombocytopenia, anemia, hepatic dysfunction, acute kidney injury, respiratory distress requiring high-flow nasal cannula (HFNC) support, and an episode of melena. Investigations showed markedly elevated lactate dehydrogenase (LDH) of 2,990 U/L, hypertriglyceridemia of 507 mg/dL, elevated ferritin, and a positive direct Coombs test, supporting the diagnosis of secondary HLH with associated autoimmune hemolytic anemia. Urine culture grew Candida. The child received fluid resuscitation, antimicrobial therapy, antifungal treatment, intravenous immunoglobulin (IVIG), intravenous methylprednisolone, packed red blood cell transfusion, respiratory support, and supportive management of organ dysfunction. Subsequent investigations demonstrated improvement in platelet count and hemoglobin, and respiratory support was successfully discontinued.
Conclusion: This case highlights the importance of recognizing secondary HLH in children with severe dengue who develop persistent fever, progressive cytopenias, hyperferritinemia, hypertriglyceridemia, and multiorgan dysfunction. Early multidisciplinary assessment and individualized management are essential. Severe dengue, secondary HLH, pediatric shock, multiple organ dysfunction syndrome, autoimmune hemolytic anemia, acute kidney injury, Influenza A.
Key words: Hemophagocytic Lymphohistiocytosis (HLH); Lactate dehydrogenase (LDH)
Introduction
Dengue is a mosquito-borne viral infection that can cause a spectrum of clinical manifestations, ranging from an uncomplicated febrile illness to severe disease characterized by plasma leakage, severe bleeding, or organ impairment. Severe dengue can be associated with profound inflammatory activation. In some patients, this may trigger secondary hemophagocytic lymphohistiocytosis, a potentially life-threatening hyperinflammatory syndrome characterized by dysregulated immune activation, persistent fever, cytopenias, hyperferritinemia, hypertriglyceridemia, and varying degrees of hepatic and other organ dysfunction. The clinical manifestations of HLH may overlap with severe dengue and sepsis, making early recognition challenging. Concurrent infections may further complicate the clinical course. Influenza A infection, bacterial or fungal infections, and immune-mediated hematological abnormalities may coexist and require individualized evaluation. This case describes a child with severe dengue complicated by suspected secondary HLH, shock, multiple organ dysfunction, autoimmune hemolytic anemia, Influenza A-positive lower respiratory tract infection, and Candida-positive urine culture.
Case Presentation
Presenting complaints
The child presented to the outpatient department with:
- High-grade, intermittent fever for one day.
- Cold and cough for two weeks, with progressively worsening productive cough.
- Generalized skin rashes.
- Multiple episodes of vomiting for one day.
- Decreased oral intake for one day.
- Decreased urine output for one day.
The vomitus contained food particles and was non-bilious and non-blood stained. There was no history of chills or rigors. There was a history of travel to Nashik approximately two weeks before presentation.
Initial clinical examination
At presentation, the child’s vital parameters were:
| Parameter | Recorded value |
|---|---|
| Pulse rate | 102/min |
| Respiratory rate | 24/min |
| Temperature | 101°F |
Systemic examination
| Parameter | Assessment Findings |
|---|---|
| Respiratory system | Bilateral air entry present |
| Cardiovascular system | No significant abnormality documented |
| Abdomen | Soft, with no hepatosplenomegaly |
| Central nervous system | Child was alert and active. |
| Skin | Generalized papular rashes |
| Icterus | Absent. |
Initial laboratory investigations
| Investigation | Initial result |
|---|---|
| Hemoglobin | 10.4 g/dL |
| Packed cell volume | 32.7% |
| Platelet count | 2,09,000/µL |
| Total leukocyte count | 3,490/µL |
The initial complete blood count showed leukopenia, with a platelet count within the normal range. A Bio Fire respiratory panel was positive for Influenza A.
Clinical Deterioration and PICU Admission
The child was initially admitted to the ward and started on intravenous fluids and intravenous antibiotics. Serial complete blood counts, relevant investigations, and strict intake-output monitoring were undertaken. By day 5 of admission, corresponding to day 6 of illness, the child developed progressive thrombocytopenia, worsening leukopenia, and a further decline in hemoglobin. Persistent fever spikes, repeated vomiting, abdominal pain, reduced oral intake, and clinical features of dehydration were also noted. In view of the progressive cytopenias, persistent fever, and clinical deterioration, severe dengue with warning signs was suspected, and the child was transferred to the PICU for close monitoring and further management.
At the time of PICU transfer, the child was in shock, with the following clinical findings:
- Tachycardia, with a heart rate of 150/min.
- Feeble peripheral pulses.
- Prolonged capillary refill time.
- Hypotension, with blood pressure below the fifth percentile for age.
An intravenous fluid bolus of 10 mL/kg was administered. Point-of-care ultrasound demonstrated preserved cardiac contractility and a collapsed inferior vena cava, suggesting reduced intravascular volume in the clinical context. A central venous line was subsequently secured for ongoing management and monitoring.
Evaluation for Secondary HLH
Persistent fever, progressive cytopenias, hepatic dysfunction, and clinical deterioration raised suspicion of secondary HLH.
Investigation
| Investigation | Patient Values |
|---|---|
| Serum ferritin | 850ng/ml |
| LDH | 2,990 U/L |
| Triglycerides | 507 mg/dL |
| C-reactive protein | 2.9 |
| Hemoglobin | 10.5 g/dL |
| Platelet count | 45,000/µL |
| Liver function tests | Elevated AST, ALT, GGT, and ALP |
| Direct Coombs test | Positive |
| Coagulation profile | Normal |
| Fibrinogen | 550mg/dl |
The findings of progressive cytopenias, elevated ferritin, hypertriglyceridemia, markedly elevated LDH, and hepatic dysfunction raised strong clinical suspicion of secondary HLH. A hematology consultation was obtained, and immunomodulatory therapy was initiated following specialist evaluation.
Diagnostic consideration: The documented findings support the clinical diagnosis of suspected secondary HLH. However, the exact ferritin and fibrinogen values, soluble CD25, natural killer cell activity where available, and other relevant criteria should be reviewed before documenting fulfillment of formal HLH-2004 diagnostic criteria. LDH elevation and a positive direct Coombs test are clinically important but are not, by themselves, diagnostic criteria for HLH.
System-Wise PICU Course and Management
Hemodynamic instability and shock
The child presented to the PICU with tachycardia, feeble peripheral pulses, prolonged capillary refill time, and hypotension. A 10 mL/kg intravenous fluid bolus was administered. POCUS demonstrated preserved cardiac contractility and a collapsed IVC, supporting reduced intravascular volume. A central venous line was secured for ongoing management and monitoring. Fluid administration and hemodynamic assessment were continued according to the child’s clinical status, with attention to the risk of fluid overload in severe dengue.
Immunomodulatory treatment for suspected secondary HLH
Following hematology consultation, the child received:
- IVIG:1 g/kg infused over 24 hours.
- Second IVIG dose: Administered around day 9 of illness.
- Intravenous methylprednisolone: 2 mg/kg/day for three days, as per the treating team’s plan.
The treatment was instituted in the context of persistent fever, progressive cytopenias, elevated inflammatory markers, hepatic dysfunction, and concern for secondary HLH.
Infectious disease management
In view of persistent fever and concern for sepsis, an infectious disease consultation was obtained from Dr. Akshata. The child was initially treated with intravenous piperacillin–tazobactam and amikacin. In view of the clinical course and persistent fever, the antimicrobial regimen was escalated to meropenem, vancomycin, and doxycycline, as per the treating team’s plan. Urine routine examination and urine culture and sensitivity were performed. Urine culture subsequently grew Candida, following which intravenous fluconazole was initiated. Meropenem was administered for eight days, and oral linezolid was subsequently initiated as part of the revised antimicrobial regimen. The significance of candiduria should be interpreted in the clinical context, including symptoms, urine findings, risk factors, and whether there was evidence of invasive fungal infection.
Renal system
On day 7 of illness, urine output decreased to less than 0.5 mL/kg/hour, raising concern for acute kidney injury.
Management included:
- Strict intake-output monitoring.
- Serial assessment of renal function and electrolytes.
- Intravenous fluid boluses as clinically indicated.
- Injection furosemide as prescribed, with monitoring of response and fluid status.
The renal course was monitored closely because of the competing risks of intravascular depletion, renal hypoperfusion, and fluid overload.
Hematological abnormalities and autoimmune hemolytic anemia
Serial complete blood counts demonstrated progressive anemia and thrombocytopenia. Further evaluation of anemia revealed elevated LDH and a positive direct Coombs test, supporting autoimmune hemolytic anemia in the appropriate clinical context. In view of significant anemia and the associated oxygen requirement, the child received one unit of packed red blood cells on day 7 of illness. Serial CBC monitoring was continued. Subsequent laboratory investigations demonstrated improvement in hematological parameters.
Latest available hematological results:
| Parameter | Latest value |
|---|---|
| Hemoglobin | 8.8 g/dL |
| Packed cell volume | 28.8% |
| Platelet count | 1,95,000/µL |
The platelet count showed substantial recovery from the nadir of 45,000/µL. Hemoglobin remained low at 8.8 g/dL, warranting continued clinical and laboratory follow-up.
Gastrointestinal bleeding
During the PICU stay, the child had one episode of melena. No further episodes of gastrointestinal bleeding were observed during subsequent monitoring. Hemoglobin levels were monitored serially, and the child received packed red blood cell transfusion in the context of associated anemia. Continued surveillance for recurrent bleeding and hemodynamic changes was undertaken.
Hepatic dysfunction
Serial liver function tests showed elevated transaminases and other liver enzymes, including AST, ALT, GGT, and ALP. In view of hepatic dysfunction, intravenous N-acetylcysteine infusion was initiated on day 8 of illness and administered according to the prescribed regimen. Serial liver function parameters were monitored, alongside supportive management and assessment for progression of organ dysfunction.
Respiratory system
On day 9 of illness, the child developed tachypnea and increased work of breathing, requiring supplemental oxygen. Oxygen support was initially provided through nasal prongs. With worsening respiratory distress, support was escalated to HFNC at a flow rate of 2 L/kg/min and an FiO₂ of 45%. HFNC support was continued for four days, with subsequent clinical improvement. The child was weaned to oxygen through nasal prongs on day 13 of illness and to room air on day 14. Following discontinuation of oxygen support, the child maintained normal oxygen saturation in room air, without further tachypnea or increased work of breathing. The respiratory deterioration occurred in the setting of documented Influenza A infection. The available information does not establish the relative contributions of viral lower respiratory tract disease, systemic inflammation, fluid shifts, or other pulmonary complications.
Nutrition and feeding
The child was initially breastfed. During the PICU stay, intravenous fluids were administered according to hydration and hemodynamic status. Enteral feeding was continued or supplemented as tolerated, with monitoring of oral intake, feeding tolerance, hydration, and nutritional requirements. Nutritional support remained an important component of recovery during the prolonged febrile illness and period of critical care.
Summary of the Clinical Timeline
| Day of illness | Major clinical events |
| Day 1- 5 | Fever, cough and cold, generalized rashes, vomiting, reduced oral intake, and decreased urine output. Initial CBC showed leukopenia. BioFire respiratory panel positive for Influenza A. |
| Day 6 | Progressive cytopenias, persistent fever, abdominal pain, vomiting, dehydration, and clinical deterioration. PICU transfer for shock and suspected severe dengue. |
| Day 7 | Oliguria suggestive of AKI hemoglobin and platelet counts declined. One unit of PRBC transfused. |
| Day 8 | Hepatic dysfunction recognized; intravenous NAC initiated. Evaluation for secondary HLH continued. |
| Day 9 | Hepatic dysfunction recognized; intravenous NAC initiated. Evaluation for secondary HLH continued. |
| Days 9–12 | HFNC support continued, with monitoring and management of respiratory and systemic complications |
| Day 13 | Weaned to oxygen through nasal prongs. |
| Day 14 | Weaned to room air; oxygenation and respiratory effort remained clinically satisfactory. |
Subsequent course Improvement in platelet count and other hematological parameters; latest available hemoglobin 8.8 g/dL and platelet count 1,95,000/µL.
Final Diagnosis
- Severe dengue, with shock and multiple organ dysfunction syndrome.
- Suspected secondary hemophagocytic lymphohistiocytosis (HLH)*in the setting of severe dengue.
- Autoimmune hemolytic anemia*, supported by a positive direct Coombs test and elevated LDH.
- *Influenza A-positive lower respiratory tract infection* complicated by respiratory distress requiring HFNC support.
- *Acute kidney injury* presenting with oliguria.
- Hepatic dysfunction, with elevated transaminases and other liver enzymes.
- *Candida-positive urine culture*, managed as fungal UTI by the treating team.
- *One episode of melena*, without documented recurrence during subsequent monitoring.
Discussion
Severe dengue and shock
Severe dengue may lead to increased vascular permeability, intravascular volume depletion, shock, bleeding, and organ impairment. Early recognition of hemodynamic compromise, careful fluid resuscitation, and frequent reassessment are central to management. Fluid therapy requires particular caution because excessive fluid administration may contribute to pulmonary edema or respiratory deterioration. In this case, the presence of tachycardia, weak peripheral pulses, prolonged capillary refill time, and hypotension, together with POCUS findings suggestive of reduced intravascular volume, supported the clinical assessment of shock.
Secondary HLH
Secondary HLH is a syndrome of uncontrolled immune activation that can occur in association with infections and other inflammatory triggers. Features that raise suspicion include persistent fever, cytopenias affecting multiple cell lines, hyperferritinemia, hypertriglyceridemia, hypofibrinogenemia, splenomegaly, and hepatic dysfunction. The coexistence of severe dengue and suspected HLH creates a diagnostic challenge because several clinical and laboratory abnormalities may occur in both conditions. In this child, progressive cytopenias, elevated ferritin, triglycerides of 507 mg/dL, marked LDH elevation, and hepatic dysfunction prompted specialist evaluation and immunomodulatory treatment. A complete assessment of the HLH criteria is important because elevated ferritin and triglycerides alone do not establish the diagnosis. Fibrinogen, soluble CD25, natural killer cell activity where available, and other clinical criteria should be considered alongside the overall course.
Autoimmune hemolytic anemia
Autoimmune hemolytic anemia results from immune-mediated destruction of red blood cells. A positive direct Coombs test supports immune-mediated hemolysis, but interpretation should be integrated with the reticulocyte count, peripheral smear, bilirubin, LDH, haptoglobin where available, and the clinical context. In this case, progressive anemia, elevated LDH, and a positive direct Coombs test supported the treating team’s diagnosis. Packed red blood cell transfusion was administered for significant anemia with associated oxygen requirement.
Concurrent Influenza A infection
The positive Bio Fire respiratory panel established the presence of Influenza A viral material in the respiratory specimen. The child’s prolonged cough followed by tachypnea and increased work of breathing necessitated escalation of oxygen support to HFNC. The subsequent improvement and successful weaning to room air were clinically favorable. The available information does not establish whether influenza contributed directly to HLH or whether it was an additional concurrent infection.
Renal and hepatic dysfunction
Oliguria in a child with severe dengue may reflect intravascular depletion, shock-related renal hypoperfusion, intrinsic kidney injury, or a combination of factors. Serial urine output, renal function, electrolytes, and fluid balance are therefore essential. Similarly, hepatic enzyme elevation may occur in severe dengue and systemic inflammatory conditions. The initiation of NAC and serial monitoring reflected the treating team’s approach to hepatic dysfunction; the indication and response should be clarified using the contemporaneous liver function results and clinical records.
Infection and antimicrobial stewardship
Persistent fever in a critically ill child warrants evaluation for concurrent infection, including bacterial and fungal sources where clinically indicated. In this case, antimicrobial therapy was escalated because of ongoing fever and concern for sepsis, while urine culture subsequently grew Candida.
Conclusion
This case highlights the importance of early recognition of secondary hemophagocytic lymphohistiocytosis in children presenting with persistent fever progressive cytopenias and multiorgan dysfunction following Influenza A infection. The associated autoimmune hemolytic anemia add complexity to the clinical course. Timely diagnostic evaluation, multidisciplinary intervention, immunomodulary treatment and comprehensive supportive care contributed to clinical improvement. A high index of suspicion for HLH in children with severe or atypical infections is essential to facilitate early treatment and improve clinical outcome.